Meet FORM³: Three Thoughtful Components, One Streamlined Weekly Routine
Modern wellness has a habit of becoming complicated.
One treatment for appetite support. Another injection or supplement for nutritional support. Multiple packages, instructions, and reminders competing for space in your routine.
FORM³ was designed around a simpler idea: three thoughtful components in one compounded prescription, administered as one weekly injection when prescribed.
The FORM³ triple-component formula brings together GLP-based metabolic care, vitamin B12, and glycine. It is available through three clinician-guided treatment paths—Tirzepatide FORM³, Semaglutide FORM³, and Microdose Tirzepatide FORM³.
Each path begins with a private online intake and an independent medical evaluation by a licensed provider. Treatment is prescribed only when clinically appropriate.
What is FORM³?
FORM³ is FORM by GBY’s signature triple-component compounded prescription for eligible weight-management patients.
Depending on the treatment path selected and the provider’s evaluation, the weekly compounded injection contains:
Semaglutide or tirzepatide for GLP-based metabolic care
Vitamin B12 for normal energy metabolism, red blood cell production, and nervous-system function
Glycine, an amino acid involved in protein synthesis and numerous metabolic processes
The formula is designed to place all three components into one coordinated weekly routine.
FORM³ is not an FDA-approved combination drug. It is a compounded prescription prepared for an individual patient and prescribed only after a licensed provider determines that it is medically appropriate.
Why three components?
FORM³ brings metabolic care and nutritional support together in one prescription.
The GLP-based component is the foundation of the weight-management treatment. Vitamin B12 and glycine provide distinct forms of nutritional support, but they do not make semaglutide or tirzepatide more effective.
That distinction matters.
FORM³ is not positioned as a secret formula that supercharges GLP-1 medication. It is a streamlined, clinician-guided treatment path designed for people who may be eligible for compounded metabolic care and prefer fewer moving parts in their weekly routine.
Component one: GLP-based metabolic care
The first component of FORM³ is either semaglutide or tirzepatide, depending on the treatment path prescribed.
Semaglutide
Semaglutide works on the GLP-1 receptor pathway. GLP-1 medications can help regulate appetite, slow digestion, promote a longer-lasting sense of fullness, and support weight-management goals when prescribed appropriately.
Semaglutide FORM³ may be considered for eligible patients seeking a clinician-guided GLP-1 weight-loss program.
Tirzepatide
Tirzepatide works on two receptor pathways: GIP and GLP-1. This dual-pathway action can help regulate appetite, slow digestion, support blood-sugar control, and support weight management.
FORM³ offers both a standard Tirzepatide FORM³ pathway and a clinician-directed Microdose Tirzepatide FORM³ pathway.
Neither medication is appropriate for every patient. Your provider reviews your health history, current medications, goals, and other clinical factors before deciding whether a FORM³ treatment path may be suitable.
Component two: vitamin B12
Vitamin B12 is an essential nutrient involved in several normal functions throughout the body.
It supports:
Normal energy metabolism
Red blood cell production
Nervous-system function
DNA synthesis
Vitamin B12 is sometimes discussed as though it provides an automatic energy boost. A more accurate way to understand its role is that the body requires B12 for normal energy metabolism. The effect of supplementation can depend on a person’s nutritional status and individual needs.
In FORM³, B12 is included as a form of nutritional support. It does not increase the weight-loss effect of semaglutide or tirzepatide.
Component three: glycine
Glycine is an amino acid used by the body in protein synthesis and many other metabolic processes.
It is involved in the production of important compounds and serves as a building block for proteins throughout the body. Like vitamin B12, glycine plays its own nutritional role within FORM³.
Glycine does not make the GLP-1 or GIP/GLP-1 medication work better. It is included to create a coordinated prescription that brings metabolic care and nutritional support into one streamlined routine.
The three FORM³ treatment paths
All FORM³ paths feature the signature triple-component formula. The primary difference is the GLP-based medication and treatment approach.
1. Tirzepatide FORM³
Tirzepatide FORM³ combines compounded tirzepatide, vitamin B12, and glycine in one weekly injection.
Tirzepatide acts on both the GIP and GLP-1 receptor pathways. This path may be considered for eligible patients seeking a dual-pathway, clinician-guided approach to weight management.
A licensed provider determines the appropriate starting dose and any adjustments over time.
Explore this path: Start the Tirzepatide FORM³ intake.
2. Semaglutide FORM³
Semaglutide FORM³ combines compounded semaglutide, vitamin B12, and glycine in one weekly injection.
Semaglutide acts on the GLP-1 receptor pathway and may help support appetite regulation and weight-management goals when prescribed appropriately.
This path may be considered for eligible patients who want a provider-guided semaglutide program with a coordinated triple-component formula.
Explore this path: Start the Semaglutide FORM³ intake.
3. Microdose Tirzepatide FORM³
Microdose Tirzepatide FORM³ combines a clinician-directed lower-dose tirzepatide pathway with vitamin B12 and glycine in one compounded weekly injection.
“Microdose” does not mean self-directed dosing or a universal dose. The treatment amount and schedule are determined by a licensed provider based on the individual patient’s evaluation.
This path may be considered when a provider determines that a lower-dose approach is clinically appropriate.
Explore this path: Start the Microdose Tirzepatide FORM³ intake.
Who may want to explore FORM³?
FORM³ may be worth discussing with a licensed provider if you:
Want a personalized online medical weight-loss program
Are interested in semaglutide or tirzepatide treatment
Prefer one coordinated weekly injection
Want clinician-managed dosing and follow-up
Are looking for metabolic care with built-in nutritional support
Want fewer separate products and instructions in your routine
Prefer a plan based on your health history rather than a standard protocol
Interest in treatment does not necessarily mean that FORM³ is appropriate for you. Eligibility depends on an independent clinical evaluation.
What FORM³ is—and what it is not
FORM³ is:
A compounded prescription
A triple-component formula
Available with semaglutide or tirzepatide
Administered as one weekly injection
Prescribed only when medically appropriate
Managed through clinician-guided care
FORM³ is not:
An FDA-approved combination medication
The same as an FDA-approved branded GLP-1 drug
A generic version of Wegovy®, Ozempic®, Mounjaro®, or Zepbound®
A guaranteed weight-loss result
Appropriate for every patient
Evidence that B12 or glycine makes a GLP-1 medication work better
A replacement for nutrition, movement, sleep, or ongoing medical care
Clear expectations are an important part of responsible metabolic care. FORM³ is designed to simplify an eligible patient’s routine—not to oversimplify the medical decision behind it.
How the FORM³ process works
1. Choose a FORM³ path
Explore Tirzepatide FORM³, Semaglutide FORM³, or Microdose Tirzepatide FORM³. You do not need to make the final clinical decision on your own.
2. Complete a private online intake
Share your health history, goals, current medications, previous weight-management experiences, and treatment preferences.
3. Receive an independent provider review
A licensed provider evaluates your information and determines whether treatment is medically appropriate. Completing an intake does not guarantee a prescription.
4. Receive personalized next steps
If treatment is appropriate, your provider determines your prescription and dosing plan. The compounded medication is fulfilled through a licensed pharmacy and delivered to you.
5. Follow your prescribed plan
Use FORM³ exactly as directed. Do not change your dose, frequency, or schedule without guidance from your provider.
Frequently asked questions about FORM³
What are the three components in FORM³?
FORM³ combines a GLP-based metabolic treatment—either semaglutide or tirzepatide—with vitamin B12 and glycine in one compounded weekly injection.
Is FORM³ a GLP-1 medication?
FORM³ includes a GLP-based medication. Semaglutide works on the GLP-1 receptor pathway, while tirzepatide works on both GIP and GLP-1 receptor pathways.
Is FORM³ FDA-approved?
No. FORM³ is a compounded prescription and is not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
Is FORM³ the same as Wegovy or Zepbound?
No. FORM³ is not the same as, equivalent to, or a generic version of an FDA-approved branded medication. Wegovy® and Zepbound® are separate FDA-approved products.
Do B12 and glycine make semaglutide or tirzepatide work better?
FORM does not claim that vitamin B12 or glycine increases the effectiveness of semaglutide or tirzepatide. The GLP-based medication provides the metabolic treatment, while B12 and glycine offer separate nutritional support.
How often is FORM³ used?
FORM³ is designed as one weekly injection when prescribed. Patients should follow the exact dose and schedule provided by their licensed clinician.
Will FORM³ give me more energy?
Vitamin B12 supports normal energy metabolism, but that does not mean every patient will feel an energy increase. Individual experiences depend on health status, nutritional needs, treatment response, and other factors.
How much weight can I lose with FORM³?
Results vary. Progress can be influenced by the prescribed medication and dose, consistency, health history, nutrition, physical activity, sleep, stress, and other factors. No specific result is guaranteed.
How do I know which FORM³ path is right for me?
A licensed provider reviews your health history and goals to determine whether semaglutide, tirzepatide, a lower-dose tirzepatide path, or another option may be appropriate.
Can anyone get a FORM³ prescription?
No. Treatment is available only to eligible patients following an independent clinical evaluation. Completing the intake does not guarantee that a prescription will be issued.
One prescription. One weekly injection. One guided plan.
Weight-management care is already personal. The routine around it does not need to feel unnecessarily complicated.
FORM³ brings GLP-based metabolic treatment, vitamin B12, and glycine together in one signature triple-component compounded prescription. With three available pathways, private online intake, and licensed-provider guidance, it offers eligible patients a more streamlined way to explore metabolic care.
Three thoughtful components. One weekly injection. Clinician guided. Delivered to you.
Explore FORM³ and start your private intake.
This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Prescription treatment is provided only when medically appropriate following an independent clinician evaluation. Completing an intake does not guarantee a prescription. FORM³ and its compounded components are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before marketing. Individual results vary.